Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline
Alzheimer's & Dementia · 2026
DOI: 10.1002/alz.71451 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Alzheimer's & Dementia, 2026. Verfasst von Jiheng Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Glymphatic System, Brain, Lymphatic System. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Joint Funds of the Natural Science Foundation of Tianjin, Tianjin Health Care Elite Prominent Young Doctor Development Program.
Themen: Demenz
Abstract (Originalsprache)
Neurotoxic protein accumulation is widely recognized as a key feature of Alzheimer's disease (AD), and increasing evidence indicates that impaired brain clearance associated with dysfunction of the meningeal lymphatic and glymphatic may contribute to this process. Disruption of these pathways may weaken homeostatic mechanisms and facilitate amyloid‑β and tau buildup. This review considers lymphatic reconstruction as a potential therapeutic direction aimed at modestly improving clearance efficiency. We summarize current findings from pharmacological approaches targeting aquaporin‐4 or vascular endothelial growth factor C signaling, non‐invasive methods such as photobiomodulation and focused ultrasound, and emerging surgical or lifestyle interventions designed to enhance drainage. Early clinical attempts, including deep cervical lymphovenous anastomosis (dCLVA), provide preliminary proof of concept but require careful validation. Progress in this field also depends on developing sensitive, non‐invasive imaging markers and defining appropriate intervention windows. By situating lymphatic modulation within the broader AD drug‐development landscape, we highlight its possible role within multimodal therapeutic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Tianjin Medical University General Hospital, Tianjin, China.
- Tianjin Neurological Institute, Key Laboratory of Post-Trauma Neuro-Repair and Regeneration in Central Nervous System, Ministry of Education, Tianjin, China.
- Department of Neurosurgery, Cangzhou People's Hospital, Cangzhou, Hebei, China.
Förderung
- National Natural Science Foundation of China
- Joint Funds of the Natural Science Foundation of Tianjin
- Tianjin Health Care Elite Prominent Young Doctor Development Program
- Young and Middle-aged Backbone Innovative Talent Program
- Clinical Talent Training '123' Climbing Plan of Tianjin Medical University
- Tianjin Key Medical Discipline (Neurosurgery) Construction Project
Zitieren
APA
Zhang, J., Zhang, J., Ding, J., Zhang, X., Wang, Y., Wei, W., Chai, Y., Zhang, S., & Chen, X. (2026). Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71451
Vancouver
Zhang J, Zhang J, Ding J, Zhang X, Wang Y, Wei W, et al. Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71451
BibTeX
@article{Zhang2026,
author = {Zhang, Jiheng and Zhang, Jiren and Ding, Jian and Zhang, Xian and Wang, Yuhua and Wei, Wei and Chai, Yan and Zhang, Shu and Chen, Xin},
title = {Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline},
journal = {Alzheimer's & Dementia},
year = {2026},
doi = {10.1002/alz.71451}
}
EUVIMED